title: Hyperinsulinemia enhances interleukin-17-induced inflammation to promote prostate cancer development in obese mice through inhibiting glycogen synthase kinase 3-mediated phosphorylation and degradation of interleukin-17 receptor.
abstract: Interleukin-17 (IL-17) plays important roles in inflammation, autoimmune diseases, and some cancers. Obese people are in a chronic inflammatory state with increased serum levels of IL-17, insulin, and insulin-like growth factor 1 (IGF1). How these factors contribute to the chronic inflammatory status that promotes development of aggressive prostate cancer in obese men is largely unknown. We found that, in obese mice, hyperinsulinemia enhanced IL-17-induced expression of downstream proinflammatory genes with increased levels of IL-17 receptor A (IL-17RA), resulting in development of more invasive prostate cancer. Glycogen synthase kinase 3 (GSK3) constitutively bound to and phosphorylated IL-17RA at T780, leading to ubiquitination and proteasome-mediated degradation of IL-17RA, thus inhibiting IL-17-mediated inflammation. IL-17RA phosphorylation was reduced, while the IL-17RA levels were increased in the proliferative human prostate cancer cells compared to the normal cells. Insulin and IGF1 enhanced IL-17-induced inflammatory responses through suppressing GSK3, which was shown in the cultured cell lines in vitro and obese mouse models of prostate cancer in vivo. These findings reveal a mechanism underlying the intensified inflammation in obesity and obesity-associated development of aggressive prostate cancer, suggesting that targeting GSK3 may be a potential therapeutic approach to suppress IL-17-mediated inflammation in the prevention and treatment of prostate cancer, particularly in obese men.
authors.affiliation: Department of Structural and Cellular Biology, Tulane University, New Orleans, LA 70112, USA.
authors.forename: Sen
authors.initials: S
authors.lastname: Liu
authors.affiliation: Department of Structural and Cellular Biology, Tulane University, New Orleans, LA 70112, USA.
authors.forename: Qiuyang
authors.initials: Q
authors.lastname: Zhang
authors.affiliation: Department of Structural and Cellular Biology, Tulane University, New Orleans, LA 70112, USA.
authors.forename: Chong
authors.initials: C
authors.lastname: Chen
authors.affiliation: Department of Structural and Cellular Biology, Tulane University, New Orleans, LA 70112, USA.
authors.forename: Dongxia
authors.initials: D
authors.lastname: Ge
authors.affiliation: Department of Structural and Cellular Biology, Tulane University, New Orleans, LA 70112, USA.
authors.forename: Yine
authors.initials: Y
authors.lastname: Qu
authors.affiliation: Department of Dermatology, Affiliated Hospital of Guangdong Medical College, Zhanjiang, Guangdong 524001, China.
authors.forename: Rongyi
authors.initials: R
authors.lastname: Chen
authors.affiliation: Department of Dermatology, Affiliated Hospital of Guangdong Medical College, Zhanjiang, Guangdong 524001, China.
authors.forename: Yi-Ming
authors.initials: YM
authors.lastname: Fan
authors.affiliation: Department of Dermatology, Affiliated Hospital of Guangdong Medical College, Zhanjiang, Guangdong 524001, China.
authors.forename: Nan
authors.initials: N
authors.lastname: Li
authors.affiliation: Department of Pathology, Ochsner Clinic Foundation, New Orleans, LA 70130, USA.
authors.forename: Wendell W
authors.initials: WW
authors.lastname: Tang
authors.affiliation: Department of Computer Science and Biostatistics Facility of RCMI Cancer Research Center, Xavier University of Louisiana, New Orleans, LA 70125, USA.
authors.forename: Wensheng
authors.initials: W
authors.lastname: Zhang
authors.affiliation: Department of Computer Science and Biostatistics Facility of RCMI Cancer Research Center, Xavier University of Louisiana, New Orleans, LA 70125, USA.
authors.forename: Kun
authors.initials: K
authors.lastname: Zhang
authors.affiliation: Department of Pathology and Laboratory Medicine, Tulane University, New Orleans, LA 70112, USA.
authors.forename: Alun R
authors.initials: AR
authors.lastname: Wang
authors.affiliation: Department of Structural and Cellular Biology, Tulane University, New Orleans, LA 70112, USA.|Tulane Cancer Center, Louisiana Cancer Research Consortium, Tulane University, New Orleans, LA 70112, USA.|Tulane Center for Stem Cell Research and Regenerative Medicine, Tulane University, New Orleans, LA 70112, USA.
authors.forename: Brian G
authors.initials: BG
authors.lastname: Rowan
authors.affiliation: Department of Structural and Cellular Biology, Tulane University, New Orleans, LA 70112, USA.|Tulane Cancer Center, Louisiana Cancer Research Consortium, Tulane University, New Orleans, LA 70112, USA.
authors.forename: Steven M
authors.initials: SM
authors.lastname: Hill
authors.affiliation: Tulane Cancer Center, Louisiana Cancer Research Consortium, Tulane University, New Orleans, LA 70112, USA.|Department of Urology, Tulane University, New Orleans, LA 70112, USA.|Department of Medicine, Tulane University, New Orleans, LA 70112, USA.
authors.forename: Oliver
authors.initials: O
authors.lastname: Sartor
authors.affiliation: Tulane Cancer Center, Louisiana Cancer Research Consortium, Tulane University, New Orleans, LA 70112, USA.|Department of Urology, Tulane University, New Orleans, LA 70112, USA.
authors.forename: Asim B
authors.initials: AB
authors.lastname: Abdel-Mageed
authors.affiliation: Department of Biostatistics and Bioinformatics, Tulane University, New Orleans, LA 70112, USA.
authors.forename: Leann
authors.initials: L
authors.lastname: Myers
authors.affiliation: Proteomics/Mass Spectrometry Facility, University at Albany, Rensselaer, NY 12144, USA.
authors.forename: Qishan
authors.initials: Q
authors.lastname: Lin
authors.affiliation: Department of Structural and Cellular Biology, Tulane University, New Orleans, LA 70112, USA.|Tulane Cancer Center, Louisiana Cancer Research Consortium, Tulane University, New Orleans, LA 70112, USA.|Tulane Center for Stem Cell Research and Regenerative Medicine, Tulane University, New Orleans, LA 70112, USA.|Department of Orthopaedic Surgery and Tulane Center for Aging, Tulane University, New Orleans, LA 70112, USA.
authors.forename: Zongbing
authors.initials: Z
authors.lastname: You
mesh_terms: D000818:Animals; D017209:Apoptosis; D049109:Cell Proliferation; D002478:Cells, Cultured; D005260:Female; D038362:Glycogen Synthase Kinase 3 / Q000378:metabolism*; D064593:Heterografts; D006801:Humans; D006946:Hyperinsulinism / Q000503:physiopathology*; D007249:Inflammation / Q000139:chemically induced* / Q000473:pathology; D018836:Inflammation Mediators / Q000378:metabolism; D020381:Interleukin-17 / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008820:Mice, Obese; D009765:Obesity / Q000150:complications*; D010766:Phosphorylation; D011471:Prostatic Neoplasms / Q000209:etiology / Q000378:metabolism / Q000473:pathology*; D053722:Receptors, Interleukin-17 / Q000378:metabolism*; D015398:Signal Transduction
chemical_list: D018836:Inflammation Mediators; D020381:Interleukin-17; D053722:Receptors, Interleukin-17; D038362:Glycogen Synthase Kinase 3
keywords: GSK3; hyperinsulinemia; interleukin-17; obesity; prostate cancer